Diabetic neuropathy in spontaneously diabetic Torii rat

Open Diabetes Journal

Volumn 4, Issue SPEC. ISSUE 1, 2011, Pages 50-54

  Sasase, Tomohiko ^a   Ohta, Takeshi ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Coefficients of valiance of R R intervals (CVR R); Diabetic neuropathy; Insulin; Nerve conduction velocity; SDT rat

Indexed keywords

3 (2 AMINOMETHYL 2,3 DIHYDRO 1H 3A AZACYCLOPENTA[A]INDEN 8 YL) 4 ANILINO 2,5 PYRROLEDIONE; ADVANCED GLYCATION END PRODUCT; ALDOSE REDUCTASE INHIBITOR; BENFOTIAMINE; DIACYLGLYCEROL; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; AUTONOMIC NEUROPATHY; BLADDER DISEASE; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPOALGESIA; INSULIN TREATMENT; MICTURITION DISORDER; MOTOR NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; RR INTERVAL; SPONTANEOUSLY DIABETIC TORII RAT;

EID: 80455174136     PISSN: None     EISSN: 18765246     Source Type: Journal    
DOI: 10.2174/1876524601104010050     Document Type: Article

References (38)

1. Boulton AJ, Malik RA, Arezzo JC. Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004; 27: 1458-86.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
4. Britland S, Sharma A. A new perspective on myelinated nerve fibre pathology in experimental diabetes. Diabetes Res 1990; 15: 69-75.
5. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 1995; 11: 193-225.
6. Yagihashi S, Sima AA. Diabetic autonomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat. Am J Pathol 1985; 121: 138-47.
7. Yagihashi S, Sima AA. Diabetic autonomic neuropathy in the BB rat. Ultrastructural and morphometric changes in sympathetic nerves. Diabetes 1985; 34: 558-64.
8. Yagihashi S, Wada R, Kamijo M, Nagai K. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993; 68: 296-307.
9. Shinohara M, Masuyama T, Shoda T, et al. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 2000; 1: 89-100.
10. Shinohara M, Masuyama T, Kakehashi A. The Spontaneously Diabetic Torii (SDT) rat with retinopathy lesions resembling those of humans. In: Shafrir E, Eds. Animal models of diabetes: frontiers in research. 2nd ed. Boca Raton (FL): CRC Press 2007; pp. 311-21.
11. Li F, Abatan OI, Kim H, et al. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 2006; 22: 669-76.
12. Oltman CL, Coppey LJ, Gellett JS, et al. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 2005; 289: E113-22.
13. Kakehashi A, Saito Y, Mori K, et al. Characteristics of diabetic retinopathy in SDT rats. Diabetes Metab Res Rev 2006; 22: 455-61.
14. Sasase T. Pathophysiological characteristics of diabetic ocular complications in Spontaneously Diabetic Torii (SDT) rat. J Ophthalmol 2010; 2010: 615-41.
15. Sasase T, Ohta T, Ogawa N, et al. Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat. Diabetes Obes Metab 2006; 8: 501-7.
16. Ohta T, Matsui K, Miyajima K, et al. Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats. Exp Anim 2007; 56: 355-62.
17. Sasase T, Morinaga H, Abe T, et al. Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. Diabetes Obes Metab 2009; 11: 1084-7.
18. Sasase T, Ohta T, Ogawa N, et al. Diabetic complications of Spontaneously Diabetic Torii rat. Diabetes 2005; 54 (Suppl 1): A221.
19. Wada R, Yajima N, Shinohara M, Yagihashi S. Peripheral neuropathy in a newly-established strain of non-obese spontaneously-onset type 2 diabetic Torii (SDT) rat. In: Diabetic Complications: Progress through Animal Models; 2003 Oct 20-21; Bethesda, USA.
20. Wada R, Yajima N, Shinohara M, Yagihashi S. Peripheral neuropathy in new non-obese type 2 diabetic model, Spontaneously Diabetic Torii (SDT) rats (in Japanese). Diabetes Frontier 2004; 15: 731.
21. Greene DA, De Jesus PV, Winegrad AI. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 1975; 55: 1326-36.
22. Malone JI, Lowitt S, Korthals JK, Salem A, Miranda C. The effect of hyperglycemia on nerve conduction and structure is age dependent. Diabetes 1996; 45: 209-15.
23. Akunne HC, Soliman KF. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology (Berl) 1987; 93: 167-72.
24. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994; 634: 7-12.
25. Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, Van Loon GR. Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides 1996; 30: 335-44.
26. Forman LJ, Estilow S, Lewis M, Vasilenko P. Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes 1986; 35: 1309-13.
27. Ohsawa M, Kamei J. Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur J Pharmacol 1999; 372: 221-8.
28. Simon GS, Dewey WL. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Ther 1981; 218: 318-23.
29. Yamada K, Hosokawa M, Fujimoto S, et al. The spontaneously diabetic Torii rat with gastroenteropathy. Diabetes Res Clin Pract 2007; 75: 127-34.
30. Nowak TV, Harrington B, Kalbfleisch JH, Amatruda JM. Evidence for abnormal cholinergic neuromuscular transmission in diabetic rat small intestine. Gastroenterology 1986; 91: 124-32.
31. Yoshida T, Nishioka H, Yoshioka K, et al. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Diabetes 1987; 36: 6-13.
32. Frimodt-Moller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 1980; 92: 318-21.
33. Malmgren A, Andersson PO, Uvelius B. Bladder function in rats with short-and long-term diabetes; effects of age and muscarinic blockade. J Urol 1989; 142: 1608-14.
34. Sasaki K, Chancellor MB, Phelan MW, et al. Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol 2002; 168: 1259-64.
35. Matsumoto Y, Torimoto K, Matsuyoshi H, et al. Long-term effects of diabetes mellitus on voiding function in a new model of type 2 diabetes mellitus, the Spontaneously Diabetic Torii (SDT) rat. Biomed Res 2009; 30: 331-5.
36. Kakehashi A, Saito Y, Ono R, et al. Prevention of Diabetic Ocular Complications in Spontaneously Diabetic Torii Rats by Aldose Reductase Inhibitor Fidarestat. Invest Ophthalmol Vis Sci 2004; 45 (Suppl): 3248.
37. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-9.
38. Stracke H, Hammes HP, Werkmann D, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes 2001; 109: 330-6.